Credelio (22 - 45 kg)
Active substance
ATC code
Species
Dogs
Indications
For the treatment of flea and tick infestations in dogs.
This veterinary medicinal product provides immediate and persistent killing activity for 1 month for fleas (Ctenocephalides felis and C. canis) and ticks (Rhipicephalus sanguineus, Ixodes ricinus, I. hexagonus and Dermacentor reticulatus).
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
For the treatment of demodicosis (caused by Demodex canis).
Dose to be administered and administration route
For oral use.
The veterinary medicinal product should be administered in accordance with the following table to ensure a dose of 20 to 43 mg lotilaner/kg bodyweight.
|
Body |
Strength and number of tablets to be administered |
||||
|
Credelio |
Credelio |
Credelio |
Credelio |
Credelio |
|
|
1.3–2.5 |
1 |
||||
|
>2.5–5.5 |
1 |
||||
|
>5.5–11.0 |
1 |
||||
|
>11.0–22.0 |
1 |
||||
|
>22.0–45.0 |
1 |
||||
|
>45 |
Appropriate combination of tablets |
||||
Use an appropriate combination of available strengths to achieve the recommended dose of 20– 43 mg/kg.
Credelio is a palatable chewable flavoured tablet. Administer the chewable tablet(s) monthly with or after food.
For the treatment of demodicosis (caused by Demodex canis):
Monthly administration of the product for two consecutive months is efficacious and leads to a marked improvement of clinical signs. Treatment should be continued until two negative skin scrapings are obtained one month apart. Severe cases may require prolonged monthly treatments. As demodicosis is a multi-factorial disease, where possible, it is advisable to also treat any underlying disease appropriately.
Adverse reactions
Target species: Dogs
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Diarrhoea[1],[2], Bloody diarrhoea1, Vomiting1,2; Anorexia1,2, Lethargy2, Polydipsia1,2; Ataxia[3], Convulsion3, Tremor3; Pruritus1,2; Inappropriate urination1, Polyuria1,2, Urinary incontinence1,2 |
1 Mild and transient
2 Typically resolve without treatment
3 Transient in most cases
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also the last section of the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 52127/5010 |
